Clinical Trial Update: SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr) [Phase 2]

View source ↗

Summary

A Phase 2 feasibility study (SATELLITE) evaluating dostarlimab in early-stage endometrial cancer with mismatch repair deficiency; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Endometrioid Endometrial Adenocarcinoma

Drugs mentioned

• JEMPERLI (DOSTARLIMAB)

Snippet

Sponsor: Queensland Centre for Gynaecological Cancer | Conditions: Endometrial Cancer Stage I, Mmr Deficiency | Phase 2 | Status: RECRUITING